By synthesizing the presented data, we can advance the hypothesis, supported by other authors [33,57,87], that chemerin is a possible link between obesity–inflammation–diabetes–atherosclerosis, and that its release could be much earlier than that of other adipokines. Here, RARRES2 is linked to obesity disorder.